Drawing on the CAS Content Collection and scientific expertise, CAS Insights offers business and research leaders perspectives on the latest developments across science and technology.
Launch of CAS Insights introduces new destination for tracking scientific innovation trends and opportunities
Dow and CAS Announce Strategic Collaboration to Accelerate R&D Capabilities and Efficiency
This collaboration leverages a tailored CAS Custom Services solution designed on a foundation of specialized CAS technologies, data science, and the CAS Content Collection to empower efficiencies in Dow’s research processes.
CAS Launches Innovation Incubator to Partner with Early-stage Innovators
Through the CAS Innovation Incubator, CAS offers resources, expertise, and potential funding to early-stage innovators to help boost their science-based ventures.
Mana.bio integrates CAS chemical substance data into its novel drug delivery AI platform
CAS is launching a collaboration with Mana.bio to enrich their proprietary database to fuel its AI engine, with an expected 70% reduction in resources allocated to molecular data acquisition and preparation.
CAS applies AI-driven approach in collaboration with INPI Brazil to transform patent examinations
CAS has completed a project with The National Institute of Industrial Property (INPI) of Brazil for an enhanced examination workflow solution for chemistry patent applications using a unique blend of technology, artificial intelligence, data, and expertise. The new solution reduced application examination times by up to 50%, and helped to reduce their multi-year application backlog.
World’s most trusted source for chemistry information, CAS, launches major biology expansion
The CAS SciFinder Discovery Platform redefines its role in drug discovery with the inclusion of unique biosequence data collection and capabilities.
April19 and CAS collaborate to accelerate real-world application of AI to discovery of novel mental health therapeutics
April19 and CAS collaborate to accelerate real-world application of AI to discovery of novel mental health therapeutics. Pairing curated data and advanced analytics with deep learning approach to drug discovery shortens pipeline and reduces cost.
CAS Launches Significant Enhancement to Predictive Retrosynthetic Capabilities in SciFinderⁿ
CAS announces significant enhancements to the predictive retrosynthetic capabilities in SciFinderⁿ. The enhanced platform uses state-of-the-art AI technology to improve both accuracy and innovativeness of predicted results.
CAS launches new brand reflecting strategic evolution to empower smarter science
CAS launched a new brand reflecting the broadening scope of its solutions and capabilities critical to advancing scientific discovery. This new brand mirrors an on-going evolution to enable new and smarter uses of scientific information as a partner to R&D leaders pursuing more efficient, collaborative, and customized innovation models.